Biomarkers for Parkinson's Disease: How Good Are They?

来源 :神经科学通报(英文版) | 被引量 : 0次 | 上传用户:tdkfire
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Parkinson\'s disease (PD) is a complex neurodegenerative disorder with no cure in sight.Clinical challenges of the disease include the inability to make a definitive diagnosis at the early stages and difficulties in predicting the disease progression.The unmet demand to identify reliable biomarkers for early diagnosis and management of the disease course of PD has attracted a lot of attention.However,only a few reported candidate biomarkers have been tried in clinical practice at the present time.Studies on PD biomarkers have often overemphasized the discovery of novel identity,whereas efforts to further evaluate such candidates are rare.Therefore,we update the new development of biomarker discovery in PD and discuss the standard process in the evaluation and assessment of the diagnostic or prognostic value of the identified potential PD biomarkers in this review article.Recent developments in combined biomarkers and the current status of clinical trials of biomarkers as outcome measures are also discussed.We believe that the combination of different biomarkers might enhance the specificity and sensitivity over a single measure that might not be sufficient for such a multiplex disease.
其他文献
With the shifting role of placebos,there is a need to develop animal models of placebo analgesia and elucidate the mechanisms underlying the effect.In the present study,male Sprague-Dawley rats with chronic inflammatory pain caused by complete Freund\'s
Ganglion cells (RGCs) are the sole output neurons of the retinal circuity.Here,we investigated whether and how dopamine D2 receptors modulate the excitability of dissociated rat RGCs.Application of the selective D2 receptor agonist quinpirole inhibited ou
Previous studies have suggested that thrombospondin-1 (TSP-1) regulates the transforming growth factor beta 1 (TGF-β1)/phosphorylated Smad2/3 (pSmad2/3) pathway.Moreover,TSP-1 is closely associated with epilepsy.However,the role of the TSP-1-regulated TGF
α-Synuclein is a soluble monomer abundant in the central nervous system.Aggregates of α-synuclein,consisting of higher-level oligomers and insoluble fibrils,have been observed in many chronic neurological diseases and are implicated in neurotoxicity and n
Scorpion venom heat-resistant peptide (SVHRP) is a component purified from Buthus martensii Karsch scorpion venom.Our previous studies have shown that SVHRP is neuroprotective in models of Alzheimer\'s disease and Parkinson\'s disease.The present stud
Dear Editor,rnSince the middle of December 2019, human-to-human transmission of novel coronavirus pneumonia (NCP, also called COVID-19) has occurred among close contacts [1].After the outbreak on January 21, 2020, it was swiftly included among the Class B
期刊
Genetic mutants of voltage-gated sodium channels (VGSCs) are considered to be responsible for the increasing number of epilepsy syndromes.Previous research has indicated that mutations of one of the VGSC genes,SCN9A (Navl.7),result in febrile seizures and
In 1919, Pio del Rio-Hortega first described a class of cells residing in the brain with a tiny soma and branched architecture distinguishable from astrocytes and neurons.These cells, called microglia or mesoglia, have come to be appreciated as resident i
期刊
In 1906,Dr.Alois Alzheimer reported a case of dementia and thought it was a new type of disease.Later,Dr.Emil Kraepelin named it Alzheimer\'s disease (AD).One hundred years later,AD has become the most common type of dementia affecting the elderly popul
期刊
The caudal forelimb area (CFA) of the mouse cortex is essential in many forelimb movements,and diverse types of GABAergic intemeuron in the CFA are distinct in the mediation of cortical inhibition in motor information processing.However,their long-range i